TCTR20220511002已完成3 期
Durability of Immunogenicity and Effectiness of the heterologous COVID-19 vaccination in kidney transplant recipients
ational Council Researach of Thailand0 个研究点目标入组 100 人开始时间: 2022年5月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 59 Years（—）
- 性别
- All
入选标准
- •Patients were all recruited from the previous studies (CVIM1, CVIM2, CVIM3 and CVIM 4)
排除标准
- •Those who declined to participate in the study
研究者
相似试验
已完成
不适用
Background factors affecting the effectiveness of the COVID-19 vaccine and their association with the microbiomes in the oral cavity and intestinal tractRegardless of the type of diseaseJPRN-UMIN000043558Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University180
尚未招募
不适用
Evaluation of safety, effectiveness and duration of immunity after vaccination against Covid-19 in patients with autoimmune rheumatic diseasesspondylitisautoimmune diseasessystemic lupus erythematosussystemic sclerodermavasculitisSjögren's syndromerheumatoid arthritismyositisRBR-108fyykdniversidade Federal de São Paulo
进行中（未招募）
1 期
Evaluation of How Long Immune Responses to SARS-CoV-2 Persist Following COVID-19 VaccinatioCOVID-19EUCTR2021-000349-42-SESahlgrenska Academy, University of Gothenburg500
已完成
不适用
Investigation of the immunogenicity and durability of second COVID-19 vaccine booster dose and their associations with the background factorsRegardless of the type of diseaseJPRN-UMIN000048396Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University100
进行中（未招募）
不适用
Immunogenicity, reactogenicity and safety of the trivalent influenza subunit vaccine Influvac® for the season 2009/2010. An open-label, baseline-controlled multi-center study in two groups: adult subjects =18 and =60 years and elderly subjects =61 years of age. - Influvac Annual Update 2009/2010EUCTR2009-010900-27-DESolvay Biologicals BV120